Investigating how inflammasomes affect melanoma progression
Role of NLRs in Melanoma
This study is looking at how a specific protein called NLRP3 might affect the growth of melanoma, a type of skin cancer, by examining genetic information from patients to see how changes in this protein could influence tumor growth and treatment resistance, which could help find new ways to tackle the disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Eastern Colorado Health Care System NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11047189 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of inflammasomes, specifically the NLRP3 protein, in the progression of melanoma, a type of skin cancer. By analyzing genetic data from melanoma patients, the researchers aim to uncover how mutations in the NLRP3 gene may contribute to tumor growth and resistance to treatment. The study will explore the molecular mechanisms behind these mutations and their impact on inflammation within tumors. This could lead to new insights into how inflammation drives cancer and potential new therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with melanoma, particularly those with advanced disease or treatment-resistant tumors.
Not a fit: Patients with non-melanoma skin cancers or those without any genetic mutations in the NLRP3 gene may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for melanoma by targeting the inflammasome pathways involved in tumor progression.
How similar studies have performed: While the role of inflammasomes in cancer is an emerging field, previous studies have shown promising results in understanding their impact on tumor biology, suggesting that this approach could yield valuable insights.
Where this research is happening
Aurora, UNITED STATES
- VA Eastern Colorado Health Care System — Aurora, United States (Active)
Researchers
- Principal investigator: Fujita, Mayumi — VA Eastern Colorado Health Care System
- Study coordinator: Fujita, Mayumi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.